The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world experience of tyrosine kinase inhibitors in patients (pt) with recurrent bone tumours (BT): A CanSaRCC study.
 
Tushar Shailesh Vora
No Relationships to Disclose
 
Hagit Peretz Soroka
No Relationships to Disclose
 
Jonathan Christopher Noujaim
Consulting or Advisory Role - Bayer; Novartis
 
Nicolas Marcoux
Honoraria - AstraZeneca; Bristol-Myers Squibb; Pfizer
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Novartis; Pfizer
 
Thierry Alcindor
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; BMS; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer/EMD Serono; Roche Canada; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); Deciphera (Inst); EMD Serono (Inst); Epizyme (Inst); Karyopharm Therapeutics (Inst); SpringWorks Therapeutics (Inst)
 
Hatim Karachiwala
No Relationships to Disclose
 
Saima Alvi
No Relationships to Disclose
 
Furqan Shaikh
No Relationships to Disclose
 
Albiruni Ryan Abdul Razak
Consulting or Advisory Role - Adaptimmune; Bayer; GlaxoSmithKline; Inhibrx; Medison
Research Funding - Abbvie; Adaptimmune; Amgen; Blueprint Medicines; Bristol-Myers Squibb; Daiichi Sankyo; Deciphera; GlaxoSmithKline; Iterion Therapeutics; Karyopharm Therapeutics; MedImmune; Merck; Neoleukin Therapeutics; Pfizer; Rain Therapeutics; Roche/Genentech; Symphogen
Expert Testimony - Medison
 
Abha A. Gupta
No Relationships to Disclose